Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption

Clinical Chemistry

Volumn 43, Issue 11, 1997, Pages 2058-2063

  Daniel Clemens, J ^a,b,c   Herrick, Michael V ^a,b   Singer, Frederick R ^a,b   Eyre, David R ^a,b  

^a Ostex International Inc   (United States)

^b JOHN WAYNE CANCER INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; PEPTIDE;

ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; DISEASE CLASSIFICATION; IMMUNOCHEMISTRY; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN DEGRADATION;

EID: 0030710492     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.11.2058     Document Type: Article

References (32)

1. Delmas PD. Biochemical markers for the assessment of bone turnover. In: Riggs LB, Melton JL III, eds. Osteoporosis: etiology, diagnosis, and management, 2nd ed. Philadelphia: Lippincott-Raven Publishers, 1995:319-33.
2. Kleerekoper M, Edelson GW. Biochemical studies in the evaluation and management of osteoporosis: current status and future prospects. Endocr Pract 1996;2:13-9.
3. Delmas PD. Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. Endocrinol Metab Clin North Am 1990;19:1-19.
4. Garnero P, Sornay-Rendu E, Chapuy M-C, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996;11:337-49.
5. Taylor AK, Kueken SA, Libanati C, Baylink DJ. Biochemical markers of bone turnover for the clinical assessment of bone metabolism. Rheum Dis Clin North Am 1994;20:589-607.
6. Prestwood KM, Pilbeam CC, Burleson JA, Woodiel FN, Delmas PD, Deftos U, Raisz LG. The short-term effects of conjugated estrogen on bone in older women. J Clin Endocrinol Metab 1994;79:366-71.
7. Uebelhart D, Gineyts E, Chapuy MD, Delmas PD. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Mineral 1990;8:87-96.
8. Robins SP, Black D, Paterson CR, Reid DM, Duncan A, Seibel MJ. Evaluation of hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases. Eur J Clin Invest 1991;21:310-5.
9. Eyre DR. New biomarkers of bone resorption [Editorial]. J Clin Endocrinol Metab 1992;74:470A-C.
10. Delmas PD, Schlemmer A, Johansen JS, Gineyts E, Riis B, Christiansen C. Urinary excretion of pyridinoline cross-links correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res 1991;6:639-44.
11. Eyre DR, Koob TJ, Van Ness KP. Quantitation of hydroxypyridinium cross-links in collagen by high performance liquid chromatography. Anal Biochem 1984;137:380-8.
12. Delmas PD, Gineyts E, Bertholin A, Garnero P, Marchand F. Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease. J Bone Miner Res 1993;8:643-8.
13. Gomez B Jr, Ardakani S, Evans BJ, Merrell LD, Jenkens DK, Kung VT. Monoclonal antibody assay for free urinary pyridinium cross-links. Clin Chem 1996;42:1168-75.
14. Gertz BJ, Shao P, Hanson DA, Quan H, Harris ST, Genant HJK, et al. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner Res 1994;9:135-42.
15. Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994;79:1693-700.
16. Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas PD. Different effects of bisphosphonates and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Min Res 1995;10:641-9.
17. Rosen HN, Dresner-Pollak R, Moses AC, Rosenblatt M, Zeind AJ, Clemens JD, Greenspan SL. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of turnover. Calcif Tiss Int 1994;54:26-9.
18. Kamel S, Brazier M, Rogez JC, Vincent O, Maamer M, Desmet G, Sebert JL. Different responses of free and peptide-bound cross-links to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency. J Clin Endocrinol Metab 1996;81: 3717-21.
19. Ebeling PR, Alley LM, Guthrie JR, Burger HG, Dennerstein L, Hopper JL, Wark JD. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 1996; 81:3366-71.
20. Eyre DR. The specificity of collagen cross-links as markers of bone and connective tissue degradation. Acta Orthop Scand 1995; 66(Suppl 266):166-70.
21. Hanson DA, Weis MAE, Bollen AM, Maslan SH, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption: quantitation of type 1 collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992:7:1251-8.
22. Nakane PK, Kawaoi A. Peroxidase-labeled antibody: a new method of conjugation. J Histochem Cytochem 1974;22:1084-91.
23. Tietz NW, ed. Textbook of clinical chemistry, 2nd ed. Philadelphia: WB Saunders, 1994:1533-6.
24. Bollen AM, Eyre DR. Bone résorption rates in children monitored by the urinary assay of collagen type I cross-linked peptides. Bone 1994;15:31-4.
25. Demers LM, Costa L, Chinchilli VM, Gaydos L, Curley E, Lipton A. Biochemical markers of bone turnover in patients with metastatic bone disease. Clin Chem 1995;41:1489-94.
26. Blumsohn A, Naylor KE, Assiri AMA, Eastell R. Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget disease. Clin Chem 1995;41:1592-8.
27. Sone T, Miyake M, Takeda N, Fukunaga M. Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: age and sex related changes and reference limits. Bone 1995;17:335-9.
28. Marshall LA, Cain DF, Dmowski WP, Chesnut CH III. Urinary N-telopeptides to monitor bone resorption while on GnRH agonist therapy. Obstet Gynecol 1996;87:350-4.
29. Hanson DA, Eyre DR. Molecular site specificity of pyridinoline and pyrrole crosslinks in type I collagen of human bone. J Biol Chem 1996;271:26508-16.
30. Apone S, Lee M, Eyre D. Osteoclasts generate cross-linked collagen N-telopeptides (NTx) but not free pyridinolines when cultured on human bone. Bone 1997;21:129-36.
31. Prestwood KM, Clemens JD, Fall PM, Pilbeam CC, Raisz LG. The effect of estrogen on serum cross-linked N-telopeptides of type I collagen [Abstract]. J Bone Miner Res 1996;11(Suppl 1): S449.
32. Greenspan SL, Holland S, Yuan W, Kher U, Clemens JD, Gertz B. Diurnal rhythm of serum NTx: a new marker to assess bone resorption and response to therapy [Abstract]. J Bone Miner Res 1996;11(Suppl 1):S442.